# |
Company Name
|
Industry Name
|
Latest Price
(Rs.) |
Price Change
Rs (%) |
Market Cap
|
Net Sales
(Rs. Cr.) |
Latest EPS
(Rs.) |
Net Profit
Margin % |
Latest
P/E |
Latest
P/BV |
---|---|---|---|---|---|---|---|---|---|---|
Bank Of India | Bank - Public | 150.4 |
5.85 (4.05%) |
Mid Cap | 47,932 | 14.1 | 8.1 | 10.7 | 1.1 | |
Bandhan Bank | Bank - Private | 184.6 |
0.8 (0.44%) |
Mid Cap | 0 | - | - | - | - | |
Balkrishna Inds. | Tyres & Allied | 2,390.1 |
55.7 (2.39%) |
Mid Cap | 9,811 | 62.7 | 9.05 | 38.1 | 5.4 | |
Aurobindo Pharma | Pharmaceuticals& Drugs | 1,102.1 |
18.45 (1.7%) |
Mid Cap | 12,792 | 33.6 | 9.24 | 32.8 | 3.4 | |
AU Small Fin. Bank | Bank - Private | 609.1 |
-8.85 (-1.43%) |
Mid Cap | 1,429 | 24.3 | 53.23 | 25.1 | - | |
Astral | Plastic Products | 2,008 |
18.6 (0.93%) |
Mid Cap | 5,159 | 21.2 | 8.74 | 94.6 | 17.9 | |
Ashok Leyland | Automobiles-Trucks/Lcv | 177.7 |
0.15 (0.08%) |
Mid Cap | 36,144 | 8.4 | 3.55 | 21.1 | 5.6 | |
Apollo Tyres | Tyres & Allied | 498.3 |
11.55 (2.37%) |
Mid Cap | 17,301 | 18.9 | 3.18 | 26.4 | 3.1 | |
APL Apollo Tubes | Steel & IronProducts | 1,549 |
-32.45 (-2.05%) |
Mid Cap | 16,166 | 27.5 | 3.93 | 56.3 | 12.5 | |
Alkem Laboratories | Pharmaceuticals& Drugs | 4,857.9 |
146 (3.1%) |
Mid Cap | 9,055 | 140.3 | 12.31 | 34.6 | 5.5 | |
Ajanta Pharma | Pharmaceuticals& Drugs | 2,137.9 |
6.45 (0.3%) |
Mid Cap | 3,743 | 58.4 | 14.67 | 36.6 | 7.3 | |
AIA Engineering | Castings/Forgings | 3,929.1 |
41.3 (1.06%) |
Mid Cap | 4,909 | 121.2 | 20.1 | 32.4 | 5.8 | |
Aditya Birla Capital | Finance - NBFC | 229.6 |
13.25 (6.12%) |
Mid Cap | 27,416 | 10.4 | 17.6 | 22.1 | 2.3 | |
Adani Wilmar | Edible Oil | 342.7 |
-0.95 (-0.28%) |
Mid Cap | 55,262 | 1.7 | 1.34 | 202.9 | 5.5 | |
ACC | Cement &ConstructionMaterials | 2,579.7 |
21.7 (0.85%) |
Mid Cap | 17,768 | 124.4 | 3.69 | 20.7 | 3.2 | |
Abbott India | Pharmaceuticals& Drugs | 25,725 |
262.8 (1.03%) |
Mid Cap | 5,349 | 539.1 | 17.8 | 47.7 | 16 | |
3M India | Diversified | 29,965.6 |
-297 (-0.98%) |
Mid Cap | 3,733 | 442.3 | 11.49 | 67.7 | 15.3 |